• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
Averhealth logo

Averhealth

Substance use monitoring and treatment solutions.

  • Court Solutions
    • Why Averhealth
    • Our Laboratory
    • Technology
  • Blog
  • Knowledge Hub
    • Press Releases
    • Testimonials
    • Newsletters
    • Annual Reports
    • Education
      • White Papers
    • Podcast
    • Webinars
  • Averhealth Academy
  • About
    • About Averhealth
    • Leadership
    • Careers
    • Job Openings
    • Certifications & Licenses
    • Our Partners
    • Conferences
    • Contact
    • Locations
    • Financial Affordability in Recovery (FAIR) Application
  • Log In
    • Provider
    • Patient
Michele Glinn

Michele Glinn

About Michele Glinn

Dr. Michele Glinn serves as the toxicologist for Averhealth’s toxicology lab in St. Louis where she assists with oversight of screening and confirmation testing for judicial customers and health care providers and assists customers with interpretation of laboratory results. She is a fellow of the American Board of Forensic Toxicology, a member of the American Academy of Forensic Sciences Standards Board Consensus Body, a member of the Society of Forensic Toxicologists and the International Association for Chemical Testing, and has served as vice president, president and past president of the Midwestern Association for Toxicology and Therapeutic Drug Monitoring.

Averhealth is Now Offering Fast and Accurate Testing For Xylazine

02.05.25

Averhealth is happy to announce that we are now offering immunoassay screening for Xylazine

Read More

Staying on Top of Emerging Drug Trends

07.24.24

At Averhealth we understand that education is an invaluable tool on the road to recovery. The ever-changing stream of new drugs hitting our streets makes preventing overdoses and knowing what to test for a constant concern.

Read More

Be Aware of Emerging Drugs Contributing to Overdoses

08.02.23

Averhealth is proud to be your knowledge hub, providing you with resources and education on the latest drug trends affecting lives across the country.

Read More

The Increasing Trend of Phenibut: Jermaine Galloway Weighs In

05.08.23

What is Phenibut and where does it come from? Phenibut is a non-FDA approved, powerful synthetic depressant that is not new to our streets across the US.

Read More

Potent Health Threats: ISO and a Horse Tranquilizer

03.06.23

Our last blog summarized some recent drug trends. Now, we turn our attention to two additional substances posing a public health threat: Isotonitazene and Xylazine.

Read More

Not Just Fentanyl: Drugs You Need to Know

02.27.23

As your knowledge hub, Averhealth is committed to sharing drug trends with you.

This blog summarizes a recent webinar presented by Dominique Delagnes, our Chief Operating Officer, about substances you need to know about.

Read More
  • Page 1
  • Page 2
  • Page 3
  • Interim pages omitted …
  • Page 6
  • Go to Next Page »

Primary Sidebar

BLOG SEARCH

Join Our Newsletter

Be the first to find out when we have exclusive news, articles or upcoming events to share.

Footer

  • Facebook
  • LinkedIn
 
866. 680. 3106
info@Averhealth.com

Newsletter Signup

Averhealth, Avertest, Aversys, and the associated logos and all associated marks are registered trademarks or service marks of Avertest, LLC.
© 2026 Avertest, LLC. All rights reserved.
The information provided on this website, including articles, laboratory guides, and compliance resources, is for educational and informational purposes only. It does not constitute professional medical advice, diagnosis, or treatment, nor does it establish a patient-provider relationship.

  • Lab Certifications
  • Non-Discrimination Notice
  • Compliance
  • Privacy Policy
  • texas Department of information resources
  • SAM registration